ClinicalTrials.Veeva

Menu

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

O

Optimal Health Research

Status

Completed

Conditions

Vitamin Deficiency

Treatments

Dietary Supplement: EZPAK
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04054505
EZ102018

Details and patient eligibility

About

The purpose of this study is to correlate the findings of an early study with current data.

Enrollment

275 patients

Sex

All

Ages

26 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Healthy volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF-1 and FT-3 are within normal limits.

A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL

Exclusion Criteria: Volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3 are outside normal limits.

A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL -

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

275 participants in 12 patient groups

Vitamin A
Active Comparator group
Description:
Rise or fall of Vitamin A after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin E
Active Comparator group
Description:
Rise or fall of Vitamin E after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin B1
Active Comparator group
Description:
Rise or fall of Vitamin B1 after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin B2
Active Comparator group
Description:
Rise or fall of Vitamin B2 after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin B6
Active Comparator group
Description:
Rise or fall of Vitamin B6 after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin B12
Active Comparator group
Description:
Rise or fall of Vitamin B12 after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin C
Active Comparator group
Description:
Rise or fall of Vitamin C after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Vitamin D
Active Comparator group
Description:
Rise or fall of Vitamin D after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Calcium
Active Comparator group
Description:
Rise or fall of Calcium after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
Iron
Active Comparator group
Description:
Rise or fall of Iron after three months
Treatment:
Dietary Supplement: Placebo
Dietary Supplement: EZPAK
IGF1
No Intervention group
Description:
Rise or fall of IGF1 after three months
FT-3
No Intervention group
Description:
Rise or fall of FT-3 after three months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems